Samsung Gets Go-Ahead For Bioepis Spinoff

Also Announces ADCs Development Deal With Phrontline

 
• By Dave Wallace
  
Samsung Biologics is moving ahead with spinning off Samsung Bioepis (Shutterstock)

More from Strategy

More from Business